Alastair Gillies

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Barriers to Timely Arteriovenous Fistula Creation: A Study of Providers and Patients

Pamela Lopez‐Vargas, Jonathan C. Craig, Martin Gallagher et al. · American Journal of Kidney Diseases · 2011 · 93 citations

Primary Care, Patient Safety, Vascular Surgery +4

Arm position and blood pressure: a risk factor for hypertension?

A. Mourad, Alastair Gillies, Bernard F. Jones et al. · Journal of Human Hypertension · 2003 · 61 citations

Hypertension, Kinesiology, Health Sciences +9

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial

Matthew A. Roberts, Helen Pilmore, Francesco L. Ierino et al. · American Journal of Kidney Diseases · 2015 · 42 citations · Full text

Hemodialysis, Urology, Cardiovascular Disease +10